FNY Managed Accounts’s Dermira, Inc. DERM Stock Holding History

FNY Managed Accounts’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-106	Closed	-$3K	–	744
2017 Q1	$3K	Buy	+106	New	+$3.42K	0.01%	697

Other funds holding DERM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FNY Managed Accounts's DERM Position: Q2 2017 in Review

FNY Managed Accounts sold out of Dermira, Inc. (DERM) in Q2 2017, closing a stake of 106 shares — an estimated $3K sold.

FNY Managed Accounts first reported a position in DERM in Q1 2017 and held it in 1 quarter. The position peaked at $3K in Q1 2017. 121 funds tracked by Wall St. Rank hold DERM as of Q2 2017.

FNY Managed Accounts reported no remaining Dermira, Inc. position as of Q2 2017 after selling out during the quarter.
FNY Managed Accounts sold 106 Dermira, Inc. shares in Q2 2017, an estimated $3K.
FNY Managed Accounts first reported a position in Dermira, Inc. in Q1 2017 and held it in 1 quarter.
FNY Managed Accounts's Dermira, Inc. position peaked at $3K in Q1 2017.
121 funds tracked by Wall St. Rank held Dermira, Inc. as of Q2 2017.

Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.